Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment

A comprehensive understanding of the dynamic changes in interleukin-6 (IL-6) levels is essential for monitoring and treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). By analyzing the correlations between IL-6 levels and health conditions, underlying diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jian, Shen, Jiawei, Han, Ying, Qiao, Qinghua, Dai, Wei, He, Bangshun, Pang, Rongrong, Zhao, Jun, Luo, Tao, Guo, Yanju, Yang, Yang, Wu, Qiuyue, Jiang, Weijun, Zhang, Jing, Zhang, Mingchao, Li, Na, Li, Weiwei, Xia, Xinyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969719/
https://www.ncbi.nlm.nih.gov/pubmed/33746945
http://dx.doi.org/10.3389/fimmu.2021.598799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969719/
https://www.ncbi.nlm.nih.gov/pubmed/33746945
http://dx.doi.org/10.3389/fimmu.2021.598799

Ejemplares similares